Cargando…

Comprehensive Transcriptomic Analysis Reveals Dysregulated Competing Endogenous RNA Network in Endocrine Resistant Breast Cancer Cells

BACKGROUND: Tamoxifen and fulvestrant, both approved for endocrine therapy, have remarkably increased the prognosis of hormone receptor-positive breast cancer patients. However, acquired resistance to endocrine therapy greatly reduces its clinical efficacy. Accumulating evidence suggests a pivotal r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Liang, Shen, Kunwei, Yin, Ni, Jiang, Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723334/ https://www.ncbi.nlm.nih.gov/pubmed/33324567 http://dx.doi.org/10.3389/fonc.2020.600487

Ejemplares similares

Hypoxia-Associated Prognostic Markers and Competing Endogenous RNA Co-Expression Networks in Breast Cancer
por: Gong, Peng-Ju, et al.
Publicado: (2020)

Integrated Analysis of a Competing Endogenous RNA Network Revealing a Prognostic Signature for Cervical Cancer
por: Xia, Leilei, et al.
Publicado: (2018)

Association of Obesity and Luminal Subtypes in Prognosis and Adjuvant Endocrine Treatment Effectiveness Prediction in Chinese Breast Cancer Patients
por: Tong, Yiwei, et al.
Publicado: (2022)

Corrigendum: Hypoxia-Associated Prognostic Markers and Competing Endogenous RNA Co-Expression Networks in Breast Cancer
por: Gong, Peng-Ju, et al.
Publicado: (2021)

Integrated Bioinformatic Analysis of a Competing Endogenous RNA Network Reveals a Prognostic Signature in Endometrial Cancer
por: Xia, Leilei, et al.
Publicado: (2019)

Long Noncoding Competing Endogenous RNA Networks in Pancreatic Cancer
por: Xiong, Guangbing, et al.
Publicado: (2021)

Flavonoids Inhibit Cancer by Regulating the Competing Endogenous RNA Network
por: Li, Chengshun, et al.
Publicado: (2022)

Comprehensive Analysis of a Competing Endogenous RNA Network Identifies Seven-lncRNA Signature as a Prognostic Biomarker for Melanoma
por: Liu, Nian, et al.
Publicado: (2019)

Impact of clinicopathological factors on extended endocrine therapy decision making in estrogen receptor–positive breast cancer
por: Chen, Weilin, et al.
Publicado: (2023)

Integrated Analysis of a Competing Endogenous RNA Network Reveals a Prognostic lncRNA Signature in Bladder Cancer
por: Peng, Mou, et al.
Publicado: (2021)

Analysis of exosomal competing endogenous RNA network response to paclitaxel treatment reveals key genes in advanced gastric cancer
por: Lei, Jun, et al.
Publicado: (2022)

Construction and Comprehensive Analysis of Dysregulated Long Noncoding RNA-Associated Competing Endogenous RNA Network in Moyamoya Disease
por: Gu, Xuefeng, et al.
Publicado: (2020)

Comprehensive Association Analysis of 21-Gene Recurrence Score and Obesity in Chinese Breast Cancer Patients
por: Tong, Yiwei, et al.
Publicado: (2021)

Rewiring of the Endocrine Network in Triple-Negative Breast Cancer
por: Li, Kaixuan, et al.
Publicado: (2022)

Circular RNA-Associated Competing Endogenous RNA Network and Prognostic Nomogram for Patients With Colorectal Cancer
por: Song, Wei, et al.
Publicado: (2019)

In silico characterization of competing endogenous RNA network in glioblastoma multiforme with a systems biology approach
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2022)

Combined Analysis of RNA Sequence and Microarray Data Reveals a Competing Endogenous RNA Network as Novel Prognostic Markers in Malignant Pleural Mesothelioma
por: Duan, Weicheng, et al.
Publicado: (2021)

Comprehensive analysis of the lncRNA-associated competing endogenous RNA network in breast cancer
por: Wang, Jing-Jing, et al.
Publicado: (2019)

Dysregulation of TLR2 Serves as a Prognostic Biomarker in Breast Cancer and Predicts Resistance to Endocrine Therapy in the Luminal B Subtype
por: Wang, Yunmei, et al.
Publicado: (2020)

A Novel Immune-Related Competing Endogenous RNA Network Predicts Prognosis of Acute Myeloid Leukemia
por: Wang, Shujuan, et al.
Publicado: (2020)

Comprehensive Transcriptome Analysis Reveals Competing Endogenous RNA Networks During Avian Leukosis Virus, Subgroup J-Induced Tumorigenesis in Chickens
por: Qiu, Lingling, et al.
Publicado: (2018)

Prognostic Biomarkers on a Competitive Endogenous RNA Network Reveals Overall Survival in Triple-Negative Breast Cancer
por: Qin, Wenxing, et al.
Publicado: (2021)

Multi-Omics Integration-Based Prioritisation of Competing Endogenous RNA Regulation Networks in Small Cell Lung Cancer: Molecular Characteristics and Drug Candidates
por: Wang, Xiao-Jun, et al.
Publicado: (2022)

Prognostic lncRNAs, miRNAs, and mRNAs Form a Competing Endogenous RNA Network in Colon Cancer
por: Huang, Qian-Rong, et al.
Publicado: (2019)

Comprehensive analyses of competing endogenous RNA networks reveal potential biomarkers for predicting hepatocellular carcinoma recurrence
por: Yan, Ping, et al.
Publicado: (2021)

Construction and comprehensive analysis of the competing endogenous RNA network in endometrial adenocarcinoma
por: Feng, Chong, et al.
Publicado: (2022)

The Role of Lithium in Management of Endocrine Tumors—A Comprehensive Review
por: Thakur, Shilpa, et al.
Publicado: (2019)

Metabolic Syndrome and Breast Cancer: Prevalence, Treatment Response, and Prognosis
por: Dong, Shuwen, et al.
Publicado: (2021)

Comprehensive characterization of endometrial competing endogenous RNA network in infertile women of childbearing age
por: Zhang, Meihua, et al.
Publicado: (2020)

Competing Endogenous RNA in Colorectal Cancer: An Analysis for Colon, Rectum, and Rectosigmoid Junction
por: Vieira, Lucas Maciel, et al.
Publicado: (2021)

Competing Endogenous RNA Networks in Glioma
por: Cen, Liang, et al.
Publicado: (2021)

Association of Biomarker Discrepancy and Treatment Decision, Disease Outcome in Recurrent/Metastatic Breast Cancer Patients
por: Lu, Yujie, et al.
Publicado: (2021)

Contemporaneous symptom networks and correlates during endocrine therapy among breast cancer patients: A network analysis
por: Jing, Feng, et al.
Publicado: (2023)

Comprehensive In Silico Analysis of a Novel Serum Exosome-Derived Competitive Endogenous RNA Network for Constructing a Prognostic Model for Glioblastoma
por: Wang, Zihao, et al.
Publicado: (2021)

RNA atlas and competing endogenous RNA regulation in tissue-derived exosomes from luminal B and triple-negative breast cancer patients
por: Wang, Ji, et al.
Publicado: (2023)

Prognostic Factors and Surgery for Breast Cancer Patients With Locoregional Recurrence: An Analysis of 5,202 Consecutive Patients
por: Huang, Jiahui, et al.
Publicado: (2021)

Construction and Comprehensive Analysis for Dysregulated Long Non-Coding RNA (lncRNA)-Associated Competing Endogenous RNA (ceRNA) Network in Gastric Cancer
por: Li, Fengxi, et al.
Publicado: (2018)

Accuracy of ultrasonographic changes during neoadjuvant chemotherapy to predict axillary lymph node response in clinical node-positive breast cancer patients
por: Li, Zhuoxuan, et al.
Publicado: (2022)

Breast Subtypes and Prognosis of Breast Cancer Patients With Initial Bone Metastasis: A Population-Based Study
por: Liu, Deyue, et al.
Publicado: (2020)

A systemic pan-cancer analysis of MPZL3 as a potential prognostic biomarker and its correlation with immune infiltration and drug sensitivity in breast cancer
por: Huang, Renhong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9njr2db9m263n2s56qn39m0tic